Hi gingerclam,Along the same lines of your thinking… on the Acadia results call in the Q&A, when Serge was asked about the potential for trofinetide to address other indications, (time: 52:30) you’d think given the successful results, there might be at least a hint of optimism here. Instead, he fluffed around, mentioned TBI, ultimately agreed yes but finished with … it’s a little premature to go there and we’re focused on Retts getting it to FDA approval. Maybe he’s just a straight shooter but no mention of Fragile X had me wondering his agenda. Keeping Neuren affordable?
Neuren Media and Analyst Coverage, page-16
-
- There are more pages in this discussion • 1,213 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.81 |
Change
-0.290(1.44%) |
Mkt cap ! $2.530B | |||
| Open | High | Low | Value | Volume |
| $20.17 | $20.17 | $19.57 | $4.720M | 238.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 9022 | $20.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.83 | 70 | 1 |
View Market Depth
| Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |